{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:12:19Z","timestamp":1790403139389,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["#12854 and #17011"],"award-info":[{"award-number":["#12854 and #17011"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["#WA1477\/6-3"],"award-info":[{"award-number":["#WA1477\/6-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG040092 and R01\/RF1 AG058657"],"award-info":[{"award-number":["R01 AG040092 and R01\/RF1 AG058657"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The deposition of neurotoxic amyloid-\u03b2 (A\u03b2) peptides in extracellular plaques in the brain parenchyma is one of the most prominent neuropathological features of Alzheimer\u2019s disease (AD), and considered to be closely related to the pathogenesis of this disease. A number of recent studies demonstrate the heterogeneity in the composition of A\u03b2 deposits in AD brains, due to the occurrence of elongated, truncated and post-translationally modified A\u03b2 peptides that have peculiar characteristics in aggregation behavior and biostability. Importantly, the detection of modified A\u03b2 species has been explored to characterize distinct stages of AD, with phosphorylated A\u03b2 being present in the clinical phase of AD. People with Down syndrome (DS) develop AD pathology by 40\u2009years of age likely due to the overproduction of A\u03b2 caused by the additional copy of the gene encoding the amyloid precursor protein on chromosome 21. In the current study, we analysed the deposition of phosphorylated and non-phosphorylated A\u03b2 species in human DS, AD, and control brains. In addition, deposition of these A\u03b2 species was analysed in brains of a series of established transgenic AD mouse models using phosphorylation-state specific A\u03b2 antibodies. Significant amounts of A\u03b2 phosphorylated at serine residue 8 (pSer8A\u03b2) and unmodified A\u03b2 were detected in the brains of DS and AD cases. The brains of different transgenic mouse models with either only human mutant amyloid precursor protein (APP), or combinations of human mutant APP, Presenilin (PS), and tau transgenes showed distinct age-dependent and spatiotemporal deposition of pSer8A\u03b2 in extracellular plaques and within the vasculature. Together, these results demonstrate the deposition of phosphorylated A\u03b2 species in DS brains, further supporting the similarity of A\u03b2 deposition in AD and DS. Thus, the detection of phosphorylated and other modified A\u03b2 species could contribute to the understanding and dissection of the complexity in the age-related and spatiotemporal deposition of A\u03b2 variants in AD and DS as well as in distinct mouse models.<\/jats:p>","DOI":"10.1186\/s40478-020-00959-w","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T08:07:53Z","timestamp":1596010073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Phosphorylated A\u03b2 peptides in human Down syndrome brain and different Alzheimer\u2019s-like mouse models"],"prefix":"10.1186","volume":"8","author":[{"given":"Sathish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Lemere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4678-2912","authenticated-orcid":false,"given":"Jochen","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"issue":"1","key":"959_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123(1):1\u201311 https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"issue":"1","key":"959_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","volume":"118","author":"C Duyckaerts","year":"2009","unstructured":"Duyckaerts C, Delatour B, Potier M-C (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118(1):5\u201336 https:\/\/doi.org\/10.1007\/s00401-009-0532-1","journal-title":"Acta Neuropathol"},{"issue":"3","key":"959_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00401-009-0485-4","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I, Boluda S, Bugiani O, Duyckaerts C, Gelpi E, Gentleman S, Giaccone G, Graeber M, Hortobagyi T, H\u00f6ftberger R, Ince P, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kov\u00e1cs GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Pikkarainen M, Revesz T, Rozemuller A, Seilhean D et al (2009) Assessment of \u03b2-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 117(3):309\u2013320 https:\/\/doi.org\/10.1007\/s00401-009-0485-4","journal-title":"Acta Neuropathol"},{"issue":"6","key":"959_CR4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8(6):595\u2013608 10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"959_CR5","doi-asserted-by":"publisher","unstructured":"Oikawa N, Walter J (2019) Presenilins and \u03b3-Secretase in membrane Proteostasis. Cells 8(3) https:\/\/doi.org\/10.3390\/cells8030209","DOI":"10.3390\/cells8030209"},{"issue":"5","key":"959_CR6","doi-asserted-by":"publisher","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","volume":"2","author":"C Haass","year":"2012","unstructured":"Haass C, Kaether C, Thinakaran G, Sisodia S (2012) Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2(5):a006270 https:\/\/doi.org\/10.1101\/cshperspect.a006270","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"959_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00401-018-1929-5","volume":"137","author":"S Walter","year":"2019","unstructured":"Walter S, Jumpertz T, H\u00fcttenrauch M, Ogorek I, Gerber H, Storck SE, Zampar S, Dimitrov M, Lehmann S, Lepka K, Berndt C, Wiltfang J, Becker-Pauly C, Beher D, Pietrzik CU, Fraering PC, Wirths O, Weggen S (2019) The metalloprotease ADAMTS4 generates N-truncated A\u03b24-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer\u2019s disease. Acta Neuropathol 137(2):239\u2013257 https:\/\/doi.org\/10.1007\/s00401-018-1929-5","journal-title":"Acta Neuropathol"},{"issue":"1","key":"959_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/00005072-199801000-00009","volume":"57","author":"TL Tekirian","year":"1998","unstructured":"Tekirian TL, Saido TC, Markesbery WR, Russell MJ, Wekstein DR, Patel E, Geddes JW (1998) N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. J Neuropathol Exp Neurol 57(1):76\u201394 https:\/\/doi.org\/10.1097\/00005072-199801000-00009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"959_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nn.2858","volume":"14","author":"T Saito","year":"2011","unstructured":"Saito T, Suemoto T, Brouwers N, Sleegers K, Funamoto S, Mihira N, Matsuba Y, Yamada K, Nilsson P, Takano J, Nishimura M, Iwata N, van Broeckhoven C, Ihara Y, Saido TC (2011) Potent amyloidogenicity and pathogenicity of A\u03b243. Nat Neurosci 14(8):1023\u20131032 https:\/\/doi.org\/10.1038\/nn.2858","journal-title":"Nat Neurosci"},{"issue":"3","key":"959_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0304-3940(96)12970-0","volume":"215","author":"TC Saido","year":"1996","unstructured":"Saido TC, Yamao-Harigaya W, Iwatsubo T, Kawashima S (1996) Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain. Neurosci Lett 215(3):173\u2013176. https:\/\/doi.org\/10.1016\/0304-3940(96)12970-0","journal-title":"Neurosci Lett"},{"key":"959_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fnagi.2019.00244","volume":"11","author":"L Garc\u00eda-Gonz\u00e1lez","year":"2019","unstructured":"Garc\u00eda-Gonz\u00e1lez L, Pilat D, Baranger K, Rivera S (2019) Emerging alternative proteinases in APP metabolism and Alzheimer\u2019s disease pathogenesis: a focus on MT1-MMP and MT5-MMP. Front Aging Neurosci 11:244 https:\/\/doi.org\/10.3389\/fnagi.2019.00244","journal-title":"Front Aging Neurosci"},{"issue":"40","key":"959_CR12","doi-asserted-by":"publisher","first-page":"15419","DOI":"10.1074\/jbc.R118.003999","volume":"293","author":"J Dunys","year":"2018","unstructured":"Dunys J, Valverde A, Checler F (2018) Are N- and C-terminally truncated A\u03b2 species key pathological triggers in Alzheimer\u2019s disease? J Biol Chem 293(40):15419\u201315428 https:\/\/doi.org\/10.1074\/jbc.R118.003999","journal-title":"J Biol Chem"},{"key":"959_CR13","doi-asserted-by":"publisher","unstructured":"Becker-Pauly C, Pietrzik CU (2017) The Metalloprotease Meprin \u03b2 is an alternative \u03b2-Secretase of APP. Front Mol Neurosci 9 https:\/\/doi.org\/10.3389\/fnmol.2016.00159","DOI":"10.3389\/fnmol.2016.00159"},{"issue":"2","key":"959_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1006\/abbi.2000.1955","volume":"381","author":"T Shimizu","year":"2000","unstructured":"Shimizu T, Watanabe A, Ogawara M, Mori H, Shirasawa T (2000) Isoaspartate formation and neurodegeneration in Alzheimer\u2019s disease. Arch Biochem Biophys 381(2):225\u2013234 https:\/\/doi.org\/10.1006\/abbi.2000.1955","journal-title":"Arch Biochem Biophys"},{"issue":"10","key":"959_CR15","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/nm.1872","volume":"14","author":"S Schilling","year":"2008","unstructured":"Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M, Kehlen A, Holzer M, Hutter-Paier B, Prokesch M, Windisch M, Jagla W, Schlenzig D, Lindner C, Rudolph T, Reuter G, Cynis H, Montag D, Demuth H-U, Rossner S (2008) Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer\u2019s disease-like pathology. Nat Med 14(10):1106\u20131111 https:\/\/doi.org\/10.1038\/nm.1872","journal-title":"Nat Med"},{"issue":"2","key":"959_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","volume":"14","author":"TC Saido","year":"1995","unstructured":"Saido TC, Iwatsubo T, Mann DM, Shimada H, Ihara Y, Kawashima S (1995) Dominant and differential deposition of distinct beta-amyloid peptide species, a beta N3(pE), in senile plaques. Neuron 14(2):457\u2013466. https:\/\/doi.org\/10.1016\/0896-6273(95)90301-1","journal-title":"Neuron"},{"issue":"5","key":"959_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.neuron.2011.07.001","volume":"71","author":"MP Kummer","year":"2011","unstructured":"Kummer MP, Hermes M, Delekarte A, Hammerschmidt T, Kumar S, Terwel D, Walter J, Pape H-C, Konig S, Roeber S, Jessen F, Klockgether T, Korte M, Heneka MT (2011) Nitration of tyrosine 10 critically enhances amyloid beta aggregation and plaque formation. Neuron 71(5):833\u2013844 https:\/\/doi.org\/10.1016\/j.neuron.2011.07.001","journal-title":"Neuron"},{"issue":"11","key":"959_CR18","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1038\/emboj.2011.138","volume":"30","author":"S Kumar","year":"2011","unstructured":"Kumar S, Rezaei-Ghaleh N, Terwel D, Thal DR, Richard M, Hoch M, Mc Donald JM, Wullner U, Glebov K, Heneka MT, Walsh DM, Zweckstetter M, Walter J (2011) Extracellular phosphorylation of the amyloid beta-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer\u2019s disease. EMBO J 30(11):2255\u20132265 https:\/\/doi.org\/10.1038\/emboj.2011.138","journal-title":"EMBO J"},{"issue":"4","key":"959_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00401-016-1546-0","volume":"131","author":"S Kumar","year":"2016","unstructured":"Kumar S, Wirths O, Stuber K, Wunderlich P, Koch P, Theil S, Rezaei-Ghaleh N, Zweckstetter M, Bayer TA, Brustle O, Thal DR, Walter J (2016) Phosphorylation of the amyloid beta-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity. Acta Neuropathol 131(4):525\u2013537 https:\/\/doi.org\/10.1007\/s00401-016-1546-0","journal-title":"Acta Neuropathol"},{"issue":"2","key":"959_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ajpath.2013.05.005","volume":"183","author":"JL Frost","year":"2013","unstructured":"Frost JL, Le KX, Cynis H, Ekpo E, Kleinschmidt M, Palmour RM, Ervin FR, Snigdha S, Cotman CW, Saido TC, Vassar RJ, St George-Hyslop P, Ikezu T, Schilling S, Demuth H-U, Lemere CA (2013) Pyroglutamate-3 amyloid-beta deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models. Am J Pathol 183(2):369\u2013381 https:\/\/doi.org\/10.1016\/j.ajpath.2013.05.005","journal-title":"Am J Pathol"},{"issue":"6","key":"959_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00401-014-1287-x","volume":"127","author":"TA Bayer","year":"2014","unstructured":"Bayer TA, Wirths O (2014) Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer\u2019s disease. Acta Neuropathol 127(6):787\u2013801 https:\/\/doi.org\/10.1007\/s00401-014-1287-x","journal-title":"Acta Neuropathol"},{"key":"959_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2017.08.007","volume":"110","author":"AE Roher","year":"2017","unstructured":"Roher AE, Kokjohn TA, Clarke SG, Sierks MR, Maarouf CL, Serrano GE, Sabbagh MS, Beach TG (2017) APP\/A\u03b2 structural diversity and Alzheimer\u2019s disease pathogenesis. Neurochem Int 110:1\u201313 https:\/\/doi.org\/10.1016\/j.neuint.2017.08.007","journal-title":"Neurochem Int"},{"issue":"12","key":"959_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/14728222.2019.1702972","volume":"23","author":"O Wirths","year":"2019","unstructured":"Wirths O, Zampar S (2019) Emerging roles of N- and C-terminally truncated A\u03b2 species in Alzheimer\u2019s disease. Expert Opin Ther Targets 23(12):991\u20131004 https:\/\/doi.org\/10.1080\/14728222.2019.1702972","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"959_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","volume":"129","author":"DR Thal","year":"2015","unstructured":"Thal DR, Walter J, Saido TC, Fandrich M (2015) Neuropathology and biochemistry of Abeta and its aggregates in Alzheimer\u2019s disease. Acta Neuropathol 129(2):167\u2013182 https:\/\/doi.org\/10.1007\/s00401-014-1375-y","journal-title":"Acta Neuropathol"},{"key":"959_CR25","doi-asserted-by":"publisher","first-page":"11359","DOI":"10.1038\/ncomms11359","volume":"7","author":"N Rezaei-Ghaleh","year":"2016","unstructured":"Rezaei-Ghaleh N, Amininasab M, Kumar S, Walter J, Zweckstetter M (2016) Phosphorylation modifies the molecular stability of beta-amyloid deposits. Nat Commun 7:11359 https:\/\/doi.org\/10.1038\/ncomms11359","journal-title":"Nat Commun"},{"issue":"8","key":"959_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.18632\/aging.100362","volume":"3","author":"S Kumar","year":"2011","unstructured":"Kumar S, Walter J (2011) Phosphorylation of amyloid beta (Abeta) peptides - a trigger for formation of toxic aggregates in Alzheimer\u2019s disease. Aging 3(8):803\u2013812. https:\/\/doi.org\/10.18632\/aging.100362","journal-title":"Aging"},{"issue":"11","key":"959_CR27","doi-asserted-by":"publisher","first-page":"8641","DOI":"10.1074\/jbc.M111.279133","volume":"287","author":"S Kumar","year":"2012","unstructured":"Kumar S, Singh S, Hinze D, Josten M, Sahl H-G, Siepmann M, Walter J (2012) Phosphorylation of amyloid-beta peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes. J Biol Chem 287(11):8641\u20138651 https:\/\/doi.org\/10.1074\/jbc.M111.279133","journal-title":"J Biol Chem"},{"key":"959_CR28","doi-asserted-by":"publisher","unstructured":"Barykin EP, Mitkevich VA, Kozin SA, Makarov AA (2017) Amyloid \u03b2 modification: a key to the sporadic Alzheimer\u2019s disease? Front Genet 8 https:\/\/doi.org\/10.3389\/fgene.2017.00058","DOI":"10.3389\/fgene.2017.00058"},{"issue":"3","key":"959_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"IT Lott","year":"2019","unstructured":"Lott IT, Head E (2019) Dementia in Down syndrome: unique insights for Alzheimer disease research. Nat Rev Neurol 15(3):135\u2013147 https:\/\/doi.org\/10.1038\/s41582-018-0132-6","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"959_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/1567205012666151020114607","volume":"13","author":"E Head","year":"2016","unstructured":"Head E, Lott IT, Wilcock DM, Lemere CA (2016) Aging in Down syndrome and the development of Alzheimer\u2019s disease neuropathology. Curr Alzheimer Res 13(1):18\u201329 https:\/\/doi.org\/10.2174\/1567205012666151020114607","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"959_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/dneu.22713","volume":"79","author":"EE Abrahamson","year":"2019","unstructured":"Abrahamson EE, Head E, Lott IT, Handen BL, Mufson EJ, Christian BT, Klunk WE, Ikonomovic MD (2019) Neuropathological correlates of amyloid PET imaging in Down syndrome. Dev Neurobiol 79(7):750\u2013766 https:\/\/doi.org\/10.1002\/dneu.22713","journal-title":"Dev Neurobiol"},{"issue":"1","key":"959_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm0196-93","volume":"2","author":"JK Teller","year":"1996","unstructured":"Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, Dagna-Bricarelli F, Scartezzini P, Bertolini S, Mann DM, Tabaton M, Gambetti P (1996) Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down\u2019s syndrome. Nat Med 2(1):93\u201395 https:\/\/doi.org\/10.1038\/nm0196-93","journal-title":"Nat Med"},{"issue":"2","key":"959_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/13506120208995241","volume":"9","author":"C Mori","year":"2002","unstructured":"Mori C, Spooner ET, Wisniewsk KE, Wisniewski TM, Yamaguch H, Saido TC, Tolan DR, Selkoe DJ, Lemere CA (2002) Intraneuronal Abeta42 accumulation in Down syndrome brain. Amyloid 9(2):88\u2013102 https:\/\/doi.org\/10.3109\/13506120208995241","journal-title":"Amyloid"},{"key":"959_CR34","doi-asserted-by":"publisher","unstructured":"Davidson YS, Robinson A, Prasher VP, Mann DMA (2018) The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer\u2019s disease in individuals with Down syndrome. Acta Neuropathol Commun 6 https:\/\/doi.org\/10.1186\/s40478-018-0559-4","DOI":"10.1186\/s40478-018-0559-4"},{"issue":"1","key":"959_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","volume":"3","author":"CA Lemere","year":"1996","unstructured":"Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ (1996) Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3(1):16\u201332 https:\/\/doi.org\/10.1006\/nbdi.1996.0003","journal-title":"Neurobiol Dis"},{"issue":"2","key":"959_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00401-006-0077-5","volume":"112","author":"K Liu","year":"2006","unstructured":"Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM-Y (2006) Characterization of Abeta11-40\/42 peptide deposition in Alzheimer\u2019s disease and young Down\u2019s syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer\u2019s disease. Acta Neuropathol 112(2):163\u2013174 https:\/\/doi.org\/10.1007\/s00401-006-0077-5","journal-title":"Acta Neuropathol"},{"issue":"5","key":"959_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-013-1107-8","volume":"125","author":"S Kumar","year":"2013","unstructured":"Kumar S, Wirths O, Theil S, Gerth J, Bayer TA, Walter J (2013) Early intraneuronal accumulation and increased aggregation of phosphorylated Abeta in a mouse model of Alzheimer\u2019s disease. Acta Neuropathol 125(5):699\u2013709 https:\/\/doi.org\/10.1007\/s00401-013-1107-8","journal-title":"Acta Neuropathol"},{"issue":"31","key":"959_CR38","doi-asserted-by":"publisher","first-page":"16059","DOI":"10.1074\/jbc.M116.728956","volume":"291","author":"N Rezaei-Ghaleh","year":"2016","unstructured":"Rezaei-Ghaleh N, Kumar S, Walter J, Zweckstetter M (2016) Phosphorylation interferes with maturation of amyloid-beta Fibrillar structure in the N terminus. J Biol Chem 291(31):16059\u201316067 https:\/\/doi.org\/10.1074\/jbc.M116.728956","journal-title":"J Biol Chem"},{"issue":"4","key":"959_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/nan.12212","volume":"41","author":"EL Ashby","year":"2015","unstructured":"Ashby EL, Miners JS, Kumar S, Walter J, Love S, Kehoe PG (2015) Investigation of Abeta phosphorylated at serine 8 (pAbeta) in Alzheimer\u2019s disease, dementia with Lewy bodies and vascular dementia. Neuropathol Appl Neurobiol 41(4):428\u2013444 https:\/\/doi.org\/10.1111\/nan.12212","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"959_CR40","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/acn3.577","volume":"5","author":"J Gerth","year":"2018","unstructured":"Gerth J, Kumar S, Rijal Upadhaya A, Ghebremedhin E, von Arnim CAF, Thal DR, Walter J (2018) Modified amyloid variants in pathological subgroups of \u03b2-amyloidosis. Ann Clin Transl Neurol 5(7):815\u2013831 https:\/\/doi.org\/10.1002\/acn3.577","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"959_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/bpa.12573","volume":"28","author":"S Kumar","year":"2018","unstructured":"Kumar S, Frost JL, Cotman CW, Head E, Palmour R, Lemere CA, Walter J (2018) Deposition of phosphorylated amyloid-\u03b2 in brains of aged nonhuman primates and canines. Brain Pathol 28(3):427\u2013430 https:\/\/doi.org\/10.1111\/bpa.12573","journal-title":"Brain Pathol"},{"issue":"Pt 3","key":"959_CR42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/brain\/awt362","volume":"137","author":"A Rijal Upadhaya","year":"2014","unstructured":"Rijal Upadhaya A, Kosterin I, Kumar S, von Arnim CAF, Yamaguchi H, Fandrich M, Walter J, Thal DR (2014) Biochemical stages of amyloid-beta peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer\u2019s disease. Brain 137(Pt 3):887\u2013903 https:\/\/doi.org\/10.1093\/brain\/awt362","journal-title":"Brain"},{"issue":"1","key":"959_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","volume":"12","author":"JL Jankowsky","year":"2017","unstructured":"Jankowsky JL, Zheng H (2017) Practical considerations for choosing a mouse model of Alzheimer\u2019s disease. Mol Neurodegener 12(1):89 https:\/\/doi.org\/10.1186\/s13024-017-0231-7","journal-title":"Mol Neurodegener"},{"issue":"17","key":"959_CR44","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, de Strooper B, Hardy J, Vassar R, Winblad B, Saido TC (2017) APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J 36(17):2473\u20132487. https:\/\/doi.org\/10.15252\/embj.201797397","journal-title":"EMBO J"},{"key":"959_CR45","doi-asserted-by":"publisher","unstructured":"Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, van Eldik LJ (2014) Using mice to model Alzheimer\u2019s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet 5 https:\/\/doi.org\/10.3389\/fgene.2014.00088","DOI":"10.3389\/fgene.2014.00088"},{"issue":"2","key":"959_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E, Wisniewski T (2017) Alzheimer\u2019s disease: experimental models and reality. Acta Neuropathol 133(2):155\u2013175 https:\/\/doi.org\/10.1007\/s00401-016-1662-x","journal-title":"Acta Neuropathol"},{"issue":"2","key":"959_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00702-011-0731-5","volume":"119","author":"N Braidy","year":"2012","unstructured":"Braidy N, Munoz P, Palacios AG, Castellano-Gonzalez G, Inestrosa NC, Chung RS, Sachdev P, Guillemin GJ (2012) Recent rodent models for Alzheimer\u2019s disease: clinical implications and basic research. J Neural Transm (Vienna) 119(2):173\u2013195 https:\/\/doi.org\/10.1007\/s00702-011-0731-5","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"959_CR48","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J Neurosci 20(11):4050\u20134058 https:\/\/doi.org\/10.1523\/JNEUROSCI.20-11-04050.2000","journal-title":"J Neurosci"},{"issue":"4","key":"959_CR49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jnr.1247","volume":"66","author":"E Rockenstein","year":"2001","unstructured":"Rockenstein E, Mallory M, Mante M, Sisk A, Masliaha E (2001) Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta (1-42). J Neurosci Res 66(4):573\u2013582 https:\/\/doi.org\/10.1002\/jnr.1247","journal-title":"J Neurosci Res"},{"issue":"19","key":"959_CR50","doi-asserted-by":"publisher","first-page":"20296","DOI":"10.1074\/jbc.M312946200","volume":"279","author":"J Davis","year":"2004","unstructured":"Davis J, Xu F, Deane R, Romanov G, Previti ML, Zeigler K, Zlokovic BV, van Nostrand WE (2004) Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch\/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem 279(19):20296\u201320306 https:\/\/doi.org\/10.1074\/jbc.M312946200","journal-title":"J Biol Chem"},{"issue":"6","key":"959_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s1389-0344","volume":"17","author":"JL Jankowsky","year":"2001","unstructured":"Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17(6):157\u2013165 https:\/\/doi.org\/10.1016\/s1389-0344(01)00067-3","journal-title":"Biomol Eng"},{"issue":"1","key":"959_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nm0198-097","volume":"4","author":"L Holcomb","year":"1998","unstructured":"Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O\u2019Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4(1):97\u2013100 https:\/\/doi.org\/10.1038\/nm0198-097","journal-title":"Nat Med"},{"issue":"3","key":"959_CR53","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39(3):409\u2013421. https:\/\/doi.org\/10.1016\/S0896-6273(03)00434-3","journal-title":"Neuron"},{"issue":"11","key":"959_CR54","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/00005072-199811000-00012","volume":"57","author":"R Hosoda","year":"1998","unstructured":"Hosoda R, Saido TC, Otvos L, Arai T, Mann DM, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Quantification of modified amyloid beta peptides in Alzheimer disease and Down syndrome brains. J Neuropathol Exp Neurol 57(11):1089\u20131095 https:\/\/doi.org\/10.1097\/00005072-199811000-00012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"959_CR55","first-page":"1823","volume":"149","author":"T Iwatsubo","year":"1996","unstructured":"Iwatsubo T, Saido TC, Mann DM, Lee VM, Trojanowski JQ (1996) Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Am J Pathol 149(6):1823\u20131830","journal-title":"Am J Pathol"},{"issue":"2","key":"959_CR56","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13(2):159\u2013170 https:\/\/doi.org\/10.1093\/hmg\/ddh019","journal-title":"Hum Mol Genet"},{"issue":"1","key":"959_CR57","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s0002-9440(10)64544-0","volume":"157","author":"A Takeuchi","year":"2000","unstructured":"Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao Ashe K, Hasegawa M, Mann DM, Hyman BT, Iwatsubo T (2000) Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol 157(1):331\u2013339. https:\/\/doi.org\/10.1016\/s0002-9440(10)64544-0","journal-title":"Am J Pathol"},{"issue":"7","key":"959_CR58","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrn2168","volume":"8","author":"FM LaFerla","year":"2007","unstructured":"LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer\u2019s disease. Nat Rev Neurosci 8(7):499\u2013509 https:\/\/doi.org\/10.1038\/nrn2168","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"959_CR59","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice. Neuron 45(5):675\u2013688 https:\/\/doi.org\/10.1016\/j.neuron.2005.01.040","journal-title":"Neuron"},{"key":"959_CR60","doi-asserted-by":"publisher","unstructured":"Takahashi RH, Nagao T, Gouras GK (2017) Plaque formation and the intraneuronal accumulation of beta-amyloid in Alzheimer\u2019s disease. Pathol Int 67(4):185\u2013193. https:\/\/doi.org\/10.1111\/pin.12520a","DOI":"10.1111\/pin.12520a"},{"issue":"32","key":"959_CR61","doi-asserted-by":"publisher","first-page":"10810","DOI":"10.1021\/bi0508237","volume":"44","author":"L Miravalle","year":"2005","unstructured":"Miravalle L, Calero M, Takao M, Roher AE, Ghetti B, Vidal R (2005) Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry 44(32):10810\u201310821 https:\/\/doi.org\/10.1021\/bi0508237","journal-title":"Biochemistry"},{"issue":"1","key":"959_CR62","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbadis.2017.07.005","volume":"1864","author":"E Cabrera","year":"2018","unstructured":"Cabrera E, Mathews P, Mezhericher E, Beach TG, Deng J, Neubert TA, Rostagno A, Ghiso J (2018) A\u03b2 truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition. Biochim Biophys Acta Mol basis Dis 1864(1):208\u2013225 https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.005","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"8","key":"959_CR63","doi-asserted-by":"publisher","first-page":"467","DOI":"10.5483\/bmbrep.2009.42.8.467","volume":"42","author":"S-H Chung","year":"2009","unstructured":"Chung S-H (2009) Aberrant phosphorylation in the pathogenesis of Alzheimer's disease. BMB Rep 42(8):467\u2013474 https:\/\/doi.org\/10.5483\/bmbrep.2009.42.8.467","journal-title":"BMB Rep"},{"issue":"6","key":"959_CR64","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00726-015-1941-1","volume":"47","author":"R Weitzdoerfer","year":"2015","unstructured":"Weitzdoerfer R, Toran N, Subramaniyan S, Pollak A, Dierssen M, Lubec G (2015) A cluster of protein kinases and phosphatases modulated in fetal Down syndrome (trisomy 21) brain. Amino Acids 47(6):1127\u20131134 https:\/\/doi.org\/10.1007\/s00726-015-1941-1","journal-title":"Amino Acids"},{"key":"959_CR65","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/B978-0-12-396456-4.00012-2","volume":"106","author":"SP Braithwaite","year":"2012","unstructured":"Braithwaite SP, Stock JB, Lombroso PJ, Nairn AC (2012) Protein phosphatases and Alzheimer's disease. Prog Mol Biol Transl Sci 106:343\u2013379 https:\/\/doi.org\/10.1016\/B978-0-12-396456-4.00012-2","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"4","key":"959_CR66","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3233\/JAD-150429","volume":"49","author":"AFN Rosenberger","year":"2016","unstructured":"Rosenberger AFN, Hilhorst R, Coart E, Garc\u00eda Barrado L, Naji F, Rozemuller AJM, van der Flier WM, Scheltens P, Hoozemans JJM, van der Vies SM (2016) Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology. J Alzheimers Dis 49(4):927\u2013943 https:\/\/doi.org\/10.3233\/JAD-150429","journal-title":"J Alzheimers Dis"},{"key":"959_CR67","doi-asserted-by":"publisher","unstructured":"Cline EN, Bicca MA, Viola KL, Klein WL  The Amyloid-\u03b2 Oligomer Hypothesis: Beginning of the Third Decade. J Alzheimers Dis 64(Suppl 1):S567\u2013S610 https:\/\/doi.org\/10.3233\/JAD-179941","DOI":"10.3233\/JAD-179941"},{"key":"959_CR68","doi-asserted-by":"publisher","unstructured":"Li S, Selkoe DJ (2020) A mechanistic hypothesis for the impairment of synaptic plasticity by soluble A\u03b2 oligomers from Alzheimer\u2019s brain. J Neurochem. https:\/\/doi.org\/10.1111\/jnc.15007","DOI":"10.1111\/jnc.15007"},{"key":"959_CR69","doi-asserted-by":"publisher","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol. 8(2):101\u2013112. https:\/\/doi.org\/10.1038\/nrm2101","DOI":"10.1038\/nrm2101"},{"issue":"19","key":"959_CR70","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1042\/CS20170033","volume":"131","author":"L J\u00e4kel","year":"2017","unstructured":"J\u00e4kel L, van Nostrand WE, Nicoll JAR, Werring DJ, Verbeek MM (2017) Animal models of cerebral amyloid angiopathy. Clin Sci 131(19):2469\u20132488 https:\/\/doi.org\/10.1042\/CS20170033","journal-title":"Clin Sci"},{"key":"959_CR71","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fnagi.2014.00032","volume":"6","author":"J Klohs","year":"2014","unstructured":"Klohs J, Rudin M, Shimshek DR, Beckmann N (2014) Imaging of cerebrovascular pathology in animal models of Alzheimer's disease. Front Aging Neurosci 6:32 https:\/\/doi.org\/10.3389\/fnagi.2014.00032","journal-title":"Front Aging Neurosci"},{"issue":"24","key":"959_CR72","doi-asserted-by":"publisher","first-page":"14088","DOI":"10.1073\/pnas.96.24.14088","volume":"96","author":"ME Calhoun","year":"1999","unstructured":"Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A 96(24):14088\u201314093 https:\/\/doi.org\/10.1073\/pnas.96.24.14088","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"959_CR73","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1750-3639.2006.tb00560.x","volume":"16","author":"MC Herzig","year":"2006","unstructured":"Herzig MC, van Nostrand WE, Jucker M (2006) Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 16(1):40\u201354 https:\/\/doi.org\/10.1111\/j.1750-3639.2006.tb00560.x","journal-title":"Brain Pathol"},{"issue":"5","key":"959_CR74","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1515\/revneuro-2014-0008","volume":"25","author":"JA Kamp","year":"2014","unstructured":"Kamp JA, Moursel LG, Haan J, Terwindt GM, Lesnik Oberstein SAMJ, van Duinen SG, van Roon-Mom WMC (2014) Amyloid \u03b2 in hereditary cerebral hemorrhage with amyloidosis-Dutch type. Rev Neurosci 25(5):641\u2013651 https:\/\/doi.org\/10.1515\/revneuro-2014-0008","journal-title":"Rev Neurosci"},{"issue":"6","key":"959_CR75","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ana.1009","volume":"49","author":"TJ Grabowski","year":"2001","unstructured":"Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49(6):697\u2013705 https:\/\/doi.org\/10.1002\/ana.1009","journal-title":"Ann Neurol"},{"issue":"3","key":"959_CR76","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/s0014-5793(97)00564-4","volume":"409","author":"C Russo","year":"1997","unstructured":"Russo C, Saido TC, DeBusk LM, Tabaton M, Gambetti P, Teller JK (1997) Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer\u2019s disease and Down\u2019s syndrome brains. FEBS Lett 409(3):411\u2013416 https:\/\/doi.org\/10.1016\/s0014-5793(97)00564-4","journal-title":"FEBS Lett"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-00959-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-020-00959-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-00959-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:52:23Z","timestamp":1627516343000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-020-00959-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["959"],"URL":"https:\/\/doi.org\/10.1186\/s40478-020-00959-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human brain tissue was collected at the time of autopsy, having obtained prior consent from the next of kin and following protocols approved by the Partners Human Research Committee at Brigham and Women\u2019s Hospital (Boston, MA, USA). All procedures and use of mice at Brigham and Women\u2019s Hospital was approved by the Harvard Medical Area Standing Committee on animals and was in compliance with state and federal regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing or conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}